EASL recommendations on treatment of hepatitis C: Final update of the series().
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guidelines Panel: Chair:; EASL Governing Board representative:; Panel members:.
J Hepatol. 2020 Nov;73(5):1170-1218. doi: 10.1016/j.jhep.2020.08.018. Epub 2020 Sep 15.
HCV virology and diagnosis.
Roger S, Ducancelle A, Le Guillou-Guillemette H, Gaudy C, Lunel F.
Clin Res Hepatol Gastroenterol. 2021 May;45(3):101626. doi: 10.1016/j.clinre.2021.101626. Epub 2021 Feb 23.
Chronic Hepatitis C: Acute Exacerbation and Alanine Aminotransferase Flare.
Kanda T, Matsumoto N, Ishii T, Arima S, Shibuya S, Honda M, Sasaki-Tanaka R, Masuzaki R, Kanezawa S, Nishizawa T, Gon Y, Ogawa M, Kogure H.
Viruses. 2023 Jan 8;15(1):183. doi: 10.3390/v15010183.
Longitudinal multi-omics analyses of the gut-liver axis reveals metabolic dysregulation in hepatitis C infection and cirrhosis.
Ali RO, Quinn GM, Umarova R, Haddad JA, Zhang GY, Townsend EC, Scheuing L, Hill KL, Gewirtz M, Rampertaap S, Rosenzweig SD, Remaley AT, Han JM, Periwal V, Cai H, Walter PJ, Koh C, Levy EB, Kleiner DE, Etzion O, Heller T.
Nat Microbiol. 2023 Jan;8(1):12-27. doi: 10.1038/s41564-022-01273-y. Epub 2022 Dec 15.
Viral hepatitis C.
Poynard T, Yuen MF, Ratziu V, Lai CL.
Lancet. 2003 Dec 20;362(9401):2095-100. doi: 10.1016/s0140-6736(03)15109-4.
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy.
Huang CF, Yu ML.
Clin Mol Hepatol. 2020 Jul;26(3):251-260. doi: 10.3350/cmh.2020.0018. Epub 2020 Mar 19.
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.
Adinolfi LE, Nevola R, Lus G, Restivo L, Guerrera B, Romano C, Zampino R, Rinaldi L, Sellitto A, Giordano M, Marrone A.
World J Gastroenterol. 2015 Feb 28;21(8):2269-80. doi: 10.3748/wjg.v21.i8.2269.
Molecular mechanisms underlying hepatitis C virus infection-related diabetes.
Ding Y, Li G, Zhou Z, Deng T.
Metabolism. 2021 Aug;121:154802. doi: 10.1016/j.metabol.2021.154802. Epub 2021 Jun 3.
Genetic and pharmacological perturbation of hepatitis-C virus entry.
Carriquí-Madroñal B, Lasswitz L, von Hahn T, Gerold G.
Curr Opin Virol. 2023 Oct;62:101362. doi: 10.1016/j.coviro.2023.101362. Epub 2023 Sep 6.
Hepatitis C virus infection in children in the era of direct-acting antiviral.
Pawlowska M, Sobolewska-Pilarczyk M, Domagalski K.
World J Gastroenterol. 2018 Jun 28;24(24):2555-2566. doi: 10.3748/wjg.v24.i24.2555.
